Overall (N = 182) | Indonesia | Kyrgyzstan | Nigeria | ||||||
---|---|---|---|---|---|---|---|---|---|
ITR | BPaL | ITR | BPaL | ITR | BPaL | ITR | BPaL | ||
Baseline assessment and monitoring of treatment efficacy | Total | 144 | 144 | 46 | 45 | 51 | 50 | 47 | 49 |
Acceptable | 106 (74%) | 127 (88%) | 35 (76%) | 38 (84%) | 43 (84%) | 47 (94%) | 28 (60%) | 42 (86%) | |
Neutral | 26 (18%) | 14 (10%) | 7 (15%) | 7 (16%) | 6 (12%) | 2 (4%) | 13 (28%) | 5 (10%) | |
Unacceptable | 12 (8%) | 3 (2%) | 4 (9%) | 0 (0%) | 2 (4%) | 1 (2%) | 6 (13%) | 2 (4%) | |
Treatment safety monitoring | Total | 141 | 140 | 44 | 43 | 52 | 52 | 45 | 45 |
Acceptable | 108 (77%) | 115 (84%) | 39 (89%) | 31 (72%) | 42 (81%) | 45 (87%) | 27 (60%) | 39 (87%) | |
Neutral | 19 (14%) | 21 (15%) | 2 (5%) | 9 (21%) | 5 (10%) | 7 (14%) | 12 (27%) | 5 (11%) | |
Unacceptable | 14 (10%) | 4 (3%) | 3 (7%) | 3 (7%) | 5 (10%) | 0 (0%) | 6 (13%) | 1 (2%) | |
Patient friendliness | Total | 136 | 133 | 43 | 43 | 39 | 39 | 54 | 51 |
Acceptable | 61 (45%) | 124 (93%) | 20 (47%) | 37 (86%) | 23 (59%) | 37 (95%) | 18 (33%) | 50 (98%) | |
Neutral | 33 (24%) | 6 (5%) | 11 (26%) | 5 (12%) | 9 (23%) | 1 (3%) | 13 (24%) | 0 (0%) | |
Unacceptable | 42 (31%) | 3 (2%) | 12 (28%) | 1 (2%) | 7 (18%) | 1 (3%) | 23 (43%) | 1 (2%) | |
Programmatic aspects | Total | 141 | 132 | 44 | 42 | 41 | 41 | 56 | 53 |
Acceptable | 85 (60%) | 110 (83%) | 30 (68%) | 29 (69%) | 28 (68%) | 33 (89%) | 27 (48%) | 48 (91%) | |
Neutral | 32 (23%) | 19 (14%) | 8 (18%) | 11 (26%) | 10 (24%) | 3 (8%) | 14 (25%) | 5 (9%) | |
Unacceptable | 24 (17%) | 3 (2%) | 6 (14%) | 2 (5%) | 3 (7%) | 1 (3%) | 15 (27%) | 0 (0%) | |
Patient support | Total | 146 | 144 | 41 | 41 | 48 | 48 | 57 | 54 |
Acceptable | 100 (69%) | 122 (85%) | 29 (71%) | 33 (81%) | 34 (71%) | 45 (92%) | 37 (65%) | 44 (82%) | |
Neutral | 27 (19%) | 19 (13%) | 9 (22%) | 8 (20%) | 6 (13%) | 3 (6%) | 12 (21%) | 8 (15%) | |
Unacceptable | 19 (13%) | 3 (2%) | 3 (7%) | 0 (0%) | 8 (17%) | 1 (2%) | 8 (14%) | 2 (4%) | |
Human resources | Total | 153 | 153 | 42 | 42 | 49 | 51 | 62 | 60 |
Acceptable | 90 (59%) | 121 (79%) | 29 (69%) | 27 (64%) | 29 (59%) | 46 (90%) | 32 (52%) | 48 (80%) | |
Neutral | 43 (28%) | 26 (17%) | 9 (21%) | 13 (31%) | 14 (29%) | 4 (8%) | 20 (32%) | 9 (15%) | |
Unacceptable | 20 (13%) | 6 (4%) | 4 (10%) | 2 (5%) | 6 (12%) | 1 (2%) | 10 (16%) | 3 (5%) | |
PSCM | Total | 79 | 74 | 25 | 25 | 28 | 26 | 26 | 24 |
Acceptable | 53 (67%) | 59 (80%) | 18 (72%) | 14 (56%) | 20 (71%) | 23 (92%) | 15 (58%) | 22 (92%) | |
Neutral | 14 (18%) | 13 (18%) | 4 (16%) | 10 (40%) | 5 (18%) | 2 (8%) | 5 (19%) | 1 (4%) | |
Unacceptable | 12 (15%) | 2 (3%) | 3 (12%) | 1 (4%) | 3 (11%) | 1 (0%) | 6 (23%) | 1 (4%) |